| Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors | Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2026-07-23 | | NCT06234098 |
|---|
| Study of ENP-501 in Peanut-Allergic and Non-Allergic Participants | Hypersensitivity, Immediate, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, food allergy, immune system disorder | Recruiting | Phase 1 / Phase 2 | 2026-04-24 | | NCT07117669 |
|---|
| Ambulatory Blood Pressure Monitoring (ABPM) Study in Hypogonadal Men | endocrine system disorder, eunuchism, gonadal disorder, hypogonadism | Not yet recruiting | Phase 4 | 2026-01-09 | | NCT07328542 |
|---|
| Pharmacokinetic and Safety Study of Metronidazole Oral Suspension in Pediatric Patients With Anaerobic Bacterial Infection | Bacterial Infections and Mycoses, Infections, bacterial infectious disease | Not yet recruiting | Phase 2 | 2025-08-28 | | NCT07146217 |
|---|
| Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration | eye disorder, macular degeneration, retinal degeneration, retinal disorder | Recruiting | Phase 1 | 2025-02-07 | | NCT06132035 |
|---|
| Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes. | eye disorder, glaucoma, ocular hypertension, open-angle glaucoma | Recruiting | Phase 3 | 2022-08-10 | | NCT05401357 |
|---|